Cited by 1,980Obesity and Health PracticesObesity, Physical Activity, DietAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index; 79 of the 165 sources its claims cite were checked for support.

Definition and diagnostic criteria of clinical obesity

Open access

Overview

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(24)00316-4

Cites

187 of 187 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

82 Own interpretation · 43 No basis given · 28 No full text of the sources · 27 Partly supported · 24 Not checked yet · 18 Supported · 12 Own method · 7 Supported so far · 7 Couldn’t confirm · 4 Sources not found · 4 Own result · 2 Not supported · 1 Mixed support · accuracy not yet measured

Verify all 19 references — free account

Show all 103 claims

  • Probably not a substantial claim. 102
  • It may state two separate claims as one. 95
156 of 156
  • The paper relies on this without support.

    Current BMI-based measures of obesity can both underestimate and overestimate adiposity and provide inadequate information about health at the individual level.

    “Current BMI-based measures of obesity can both underestimate and overestimate adiposity and provide inadequate information about health at the individual level, which undermines medically-sound approaches to health care and policy.”
  • The paper relies on this without support.

    Clinical obesity can lead to severe end-organ damage, causing life-altering and potentially life-threatening complications.

    “Clinical obesity can lead to severe end-organ damage, causing life-altering and potentially life-threatening complications (eg, heart attack, stroke, and renal failure).”
  • The paper relies on this without support.

    The risk of mortality and obesity-associated diseases can rise as a continuum across increasing levels of fat mass.

    “Although the risk of mortality and obesity-associated diseases can rise as a continuum across increasing levels of fat mass”
  • The paper relies on this without support.

    Obesity is a highly heterogenous condition.

    “Other critics point to more objective issues, such as the fact that obesity is a highly heterogenous condition and that many people with excess adiposity have no signs of ongoing illness.”
  • The paper relies on this without support.

    Many people with excess adiposity have no signs of ongoing illness.

    “Other critics point to more objective issues, such as the fact that obesity is a highly heterogenous condition and that many people with excess adiposity have no signs of ongoing illness.”
  • The paper relies on this without support.

    The illness directly caused by obesity is yet to be defined.

    “This dispute, however, reveals a crucial missing piece in the way obesity is conceptualised: because the illness directly caused by obesity is yet to be defined, obesity lacks a precise clinical identity.”
  • The paper relies on this without support.

    The phenotype of obesity is still only defined by corpulence.

    “In fact, the phenotype of obesity is still only defined by corpulence, despite evidence that excess adiposity can also have clinical manifestations and cause illness by inducing dysfunction of various organs and tissues.”
  • The paper relies on this without support.

    Excess adiposity can also have clinical manifestations and cause illness by inducing dysfunction of various organs and tissues.

    “In fact, the phenotype of obesity is still only defined by corpulence, despite evidence that excess adiposity can also have clinical manifestations and cause illness by inducing dysfunction of various organs and tissues.”
  • The paper relies on this without support.

    The manifestations of obesity as an illness have not been adequately characterised.

    “The manifestations of obesity as an illness, however, have not been adequately characterised.”
    “The manifestations of obesity as an illness, however, have not been adequately characterised.”
  • The paper relies on this without support.

    Weight-based bias and stigma are major obstacles in efforts to effectively prevent and treat obesity.

    “Weight-based bias and stigma are major obstacles in efforts to effectively prevent and treat obesity; health-care professionals and policy makers should receive proper training to address this important issue of obesity.”
  • The paper relies on this without support.

    The diagnosis of disease in other areas of medicine is generally based on the detection of signs and symptoms induced by dysfunction of organs or the whole organism.

    “The diagnosis of disease in other areas of medicine is generally based on the detection of signs and symptoms induced by dysfunction of organs or the whole organism (see section Chronic diseases).”
  • The paper relies on this without support.

    The illness specifically caused by obesity had not been clinically characterised before this Commission.

    “As the illness specifically caused by obesity has not been clinically characterised before this Commission, there are currently no available anthropometric measures or biomarkers that have sufficiently robust diagnostic accuracy to conceive a single-criterion, diagnostic model of clinical obesity (as there is for diabetes).”
  • The paper relies on this without support.

    Obesity facilitates the development of several mental disorders.

    “Although this Commission recognises that obesity facilitates the development of several mental disorders, the mechanisms behind such associations are complex and not fully understood.”
  • The paper relies on this without support.

    Many medications used to treat mental disorders promote weight gain, exacerbating obesity.

    “Unfortunately, many medications used to treat mental disorders promote weight gain, exacerbating obesity.”
  • The authors state this as an assumption.

    Resolution of manifestations of clinical obesity (ie, restoring normal organ function) should have a positive effect on an individual’s experience of illness and on quality of life.

    “It is plausible to assume that resolution of manifestations of clinical obesity (ie, restoring normal organ function) should have a positive effect on an individual’s experience of illness and on quality of life.”
  • The authors state this as an assumption.

    All diagnostic criteria of clinical obesity assume exclusion of obvious other causes of organ dysfunction or signs and symptoms.

    “Importantly, all diagnostic criteria of clinical obesity assume exclusion of obvious other causes of organ dysfunction or signs and symptoms.”
  • The paper relies on this without support.

    Traditional grading and scoring systems of obesity and health insurance policies typically include a mix of individual alterations of organ structure or function and diseases in their own right, all incorrectly referred to as comorbidities or complications.

    “Traditional grading and scoring systems of obesity and health insurance policies typically include a mix of individual alterations of organ structure or function (eg, MASLD) and diseases in their own right (eg, type 2 diabetes, osteoarthritis, and cancer)—all incorrectly referred to as comorbidities or complications.”
  • The paper relies on this without support.

    The diagnosis of type 2 diabetes reflects a disease state characterised by its own pathophysiology and distinct clinical manifestations.

    “this diagnosis reflects a disease state characterised by its own pathophysiology and distinct clinical manifestations (eg, fatigue, polyuria, and polydipsia).”
  • The paper relies on this without support.

    Not all possible clinical manifestations of clinical obesity occur in the same individual, and different clinical manifestations have distinct effects on quality of life and prognosis.

    “not all possible clinical manifestations of clinical obesity occur in the same individual, and different clinical manifestations have distinct effects on quality of life and prognosis.”
  • The paper relies on this without support.

    The individual level of risk varies substantially with several factors (eg, ethnicity, family history, or fat distribution).

    “the individual level of risk varies substantially with several factors (eg, ethnicity, family history, or fat distribution)”
  • The paper relies on this without support.

    Obesity exerts a substantial and broad effect on people’s lives, beyond just health. Social, financial, and emotional effects of obesity compound the health effect of excess adiposity.

    “Obesity exerts a substantial and broad effect on people’s lives, beyond just health. Social, financial, and emotional effects of obesity (especially experience of societal stigma) compound the health effect of excess adiposity.”
  • The paper relies on this without support.

    Much remains unknown about the cause, pathophysiology, management, and societal effect of obesity.

    “much remains unknown about its cause, pathophysiology, management, and societal effect.”
  • The paper relies on this without support.

    The use of diagnostic criteria is a well established approach for identification of many chronic illnesses.

    “the use of diagnostic criteria is a well established approach for identification of many chronic illnesses.”
  • The paper relies on this without support.

    Widespread weight bias, stereotypes, and stigma contribute towards a pejorative connotation to various terms related to excess adiposity, including the name obesity itself.

    “widespread weight bias, stereotypes, and stigma contribute towards a pejorative connotation to various terms related to excess adiposity, including the name obesity itself.”
  • The paper relies on this without support.

    Every disease is characterised by its distinct pathophysiology, clinical manifestations, evolution, and prognosis.

    “Every disease is characterised by its distinct pathophysiology, clinical manifestations, evolution, and prognosis.”
25 of 25

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 185 references

Cited by

Sorted by citations

Items 1,601–1,700 of 1,980

Metadata

Authors
Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., le Roux, C. W., Sattar, N., Baur, L. A., Morrison, K. M., Misra, A., Kadowaki, T., Tham, K. W., Sumithran, P., Garvey, W. T., Kirwan, J. P., Fernández-Real, J.-M., Corkey, B. E., Toplak, H., Kokkinos, A., Kushner, R. F., Branca, F., Valabhji, J., Blüher, M., Bornstein, S. R., Grill, H. J., Ravussin, E., Gregg, E., Al Busaidi, N. B., Alfaris, N. F., Al Ozairi, E., Carlsson, L. M. S., Clément, K., Després, J.-P., Dixon, J. B., Galea, G., Kaplan, L. M., Laferrère, B., Laville, M., Lim, S., Luna Fuentes, J. R., Mooney, V. M., Nadglowski, J., Urudinachi, A., Olszanecka-Glinianowicz, M., Pan, A., Pattou, F., Schauer, P. R., Tschöp, M. H., van der Merwe, M. T., Vettor, R., & Mingrone, G.
Affiliations
  • King's College London (GB)
  • University of Washington (US)
  • University of Colorado Anschutz (US)
  • Hospital Alemão Oswaldo Cruz (BR)
  • University of Liverpool (GB)
  • The Alfred Hospital (AU)
  • Harvard University (US)
  • Eli Lilly (United Kingdom) (GB)
  • National Institute for Health and Care Research (GB)
  • University College Dublin (IE)
  • University of Glasgow (GB)
  • The University of Sydney (AU)
  • McMaster Children's Hospital (CA)
  • National Diabetes Obesity and Cholesterol Foundation (IN)
  • Toranomon Hospital (JP)
  • Nanyang Technological University (SG)
  • University of Alabama at Birmingham (US)
  • Pennington Biomedical Research Center (US)
  • Boston University (US)
  • University of Graz (AT)
  • National and Kapodistrian University of Athens (GR)
  • Northwestern University (US)
  • World Health Organization (CH)
  • National Health Service (GB)
  • Helmholtz Munich (DE)
  • University of Pennsylvania (US)
  • Royal College of Surgeons in Ireland (IE)
  • King Fahd Medical City (SA)
  • University of Gothenburg (SE)
  • Inserm (FR)
  • VITAM - Centre de recherche en santé durable (CA)
  • Swinburne University of Technology (AU)
  • World Health Organization Regional Office for Europe (DK)
  • Dartmouth College (US)
  • Columbia University Irving Medical Center (US)
  • Lyon 1 Université (FR)
  • Seoul National University (KR)
  • Huazhong University of Science and Technology (CN)
  • University of Pretoria (ZA)
  • University of Padua (IT)
  • Università Cattolica del Sacro Cuore (IT)
Corresponding author
Rubino, Francesco
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2025-03
Volume
13
Issue
3
Pages
221-262
ISSN
2213-8587 (ISSN-L)
OpenAlex
W4406352787
Cited by
1,811
References
185
Citations by year
2026: 1028 · 2025: 782
FWCI
182.26
Type
journal article
Language
en
Update notices
erratum (2025-03-01)
Open access
Locations
  • The Lancet Diabetes & Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
  • HAL (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • World Health Organization
  • National Institute of General Medical Sciences (U54GM104940)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U24DK132733, UE5DK137285)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
clinical obesity, excess adiposity, preclinical obesity, diagnostic criteria, body mass index limitations, anthropometric measures, waist circumference, waist-to-height ratio, waist-to-hip ratio, body fat measurement, obesity as chronic disease, obesity-related comorbidities, non-communicable diseases, obesity policy, expert consensus, lived experience of obesity, health risk assessment, target organ damage

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-20, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-20 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review